Galmed Pharmaceuticals Ltd. (GLMD) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $2.39 | -70.4% |
| 2024 | $8.08 | -73.1% |
| 2023 | $30.00 | -76.5% |
| 2022 | $127.80 | +545.5% |
| 2021 | $19.80 | +1366.7% |
| 2020 | $1.35 | +39.2% |
| 2019 | $0.97 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $2.39 | -70.4% |
| 2024 | $8.08 | -73.1% |
| 2023 | $30.00 | -76.5% |
| 2022 | $127.80 | +545.5% |
| 2021 | $19.80 | +1366.7% |
| 2020 | $1.35 | +39.2% |
| 2019 | $0.97 | — |